2022 Parainfluenza Virus Infection Pipeline Insights: Featuring AlloVir, Ansun Biopharma and Moderna Therapeutics
GlobeNewswire
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Parainfluenza Virus Infection - Pipeline Insight, 2022" clinical trials has been..